Once a cancer treatment receives FDA approval, it can be marketed and prescribed to patients. However, post-approval monitoring continues to ensure long-term safety and effectiveness. This may involve additional post-marketing surveillance studies and reporting of adverse events. The FDA also has the authority to withdraw approval if safety concerns arise.